Surgical Adhesive Tape — BharatSeal Smart DPR (May 2026)
Fresh May 2026 cost structure built from live market inputs. Template version 2, authored 2026-05-15 · next review 2026-08-13.
Why this market is hot in 2026
The Indian medical device market is valued at $11 billion in 2024 and is projected to reach $50 billion by 2030, growing at a CAGR of 15-17%. Consumables, including surgical tapes, constitute a significant portion of this market, driven by increasing healthcare access and medical tourism. — Invest India, IBEF Medical Devices Report, May 2026
Government initiatives like 'Make in India' and the Production Linked Incentive (PLI) scheme for medical devices are encouraging domestic manufacturing. Surgical adhesive tapes, being a Class A medical device, benefit from a simplified regulatory pathway under the Medical Device Rules 2017, making market entry easier for MSMEs. — Department of Pharmaceuticals, MoC&F, CDSCO Medical Device Rules 2017
Demand for affordable, quality medical consumables is rising due to schemes like Ayushman Bharat and expanding private healthcare infrastructure in Tier-2/3 cities. Local manufacturers can compete effectively on price and supply chain efficiency against imports. — BharatSeal Editorial estimate based on 2026 healthcare spending trends
Product description
Industrial shed in a Tier-2/3 city, minimum 1000 sqft, with 3-phase power, proper drainage, and clean room facility.. The unit produces 5,70,000 roll (2.5cm x 9.1m) per year at full nameplate capacity, with a 5-year ramp from 30% to 90% utilisation. Sold at an average ₹20 per roll (2.5cm x 9.1m) blended across SKUs and channels. Target buyers span Government hospitals (e.g., AIIMS, ESIC, State Health Dept tenders), Private hospitals & clinics (e.g., Apollo, Fortis, local nursing homes), Retail pharmacies (e.g., Apollo Pharmacy, MedPlus, local chemists), with online distribution via Government e-Marketplace (GeM), IndiaMART (B2B for distributors & hospitals), TradeIndia (B2B for bulk orders & exports).
Industrial scenario (2026)
The Indian medical device market is valued at $11 billion in 2024 and is projected to reach $50 billion by 2030, growing at a CAGR of 15-17%. Consumables, including surgical tapes, constitute a significant portion of this market, driven by increasing healthcare access and medical tourism. Government initiatives like 'Make in India' and the Production Linked Incentive (PLI) scheme for medical devices are encouraging domestic manufacturing. Surgical adhesive tapes, being a Class A medical device, benefit from a simplified regulatory pathway under the Medical Device Rules 2017, making market entry easier for MSMEs. Demand for affordable, quality medical consumables is rising due to schemes like Ayushman Bharat and expanding private healthcare infrastructure in Tier-2/3 cities. Local manufacturers can compete effectively on price and supply chain efficiency against imports. BharatSeal's editorial layer (12 'Hot in 2026' + 10 'Starter-friendly' tags) places this project in the wider 2026 Indian MSME landscape. Macro tailwinds include current PMEGP margin-money (15% urban, 25% rural, 35% special-category) plus the relevant sector schemes flagged below.
Basis & presumption of report
This DPR is prepared on the basis of BharatSeal's live market_inputs snapshot dated 2026-05-15, with capex prices, raw-material rates, wages, fuel, electricity and rent values resolved from primary public sources cited in Section 19. Plant capacity is 5,70,000 roll (2.5cm x 9.1m)/year. Working capital cycle is 4 months. Bank loan is sized at 75% of project cost over 5 years at 9.75% p.a., with PMEGP margin money assumed at 15% and beneficiary contribution at 10%. Depreciation follows the asset-specific lives in Section 16. Income tax is provided at 25% on positive PBT. Sundry debtors and creditors are taken at 15-day equivalents of revenue and COGS respectively — Indian MSME finance norm. The 5-year utilisation ramp is editorial (BharatSeal industry benchmark) and is the largest single judgement in the model — three scenarios (Section 6) and a sensitivity grid (Section 7) stress-test it.
Manufacturing process
- 1Inward goods receipt + quality screeningVerify raw-material specifications against the BOM; record batch numbers in inventory register.⏱ 30-60 min per inward
- 2Preparation + pre-processingCleaning, sorting, grading, or pre-treatment as per the sector's standard production sequence.⏱ 1-3 hr per batch
- 3Primary production / processingCore production using the plant + machinery listed in Section 12. Operator-hours sized for 5-person crew across skill levels.⏱ Continuous
- 4In-process quality checkMid-stage parameter checks against the QC protocol below; rejected items returned for rework or scrapped.⏱ 10-20 min per QC cycle
- 5Finishing, packing + labellingPack to retail/wholesale unit, apply MRP and statutory labels (BIS / FSSAI / nutritional / batch / expiry as applicable).⏱ 30-60 min per finished batch
- 6Outward dispatch + invoiceGST-compliant invoice; e-Way Bill for shipments > ₹50k inter-state; logistics tie-up with local 3PL.⏱ 15-30 min per dispatch
Inspection & quality control
| Stage | Parameter | Spec | Method |
|---|---|---|---|
| Incoming material | Visual + spec conformance | Per BOM tolerance band | Visual + supplier COA cross-check |
| Pre-processing | Moisture / purity / grade | Per BIS / sector standard | Moisture meter / refractometer / sample test |
| In-process | Critical control parameters | Process-window per SOP | On-line sensor / batch sample |
| Finished good | Final spec verification | Per BIS-cited compliance row | Lab QC + retain sample (12 months) |
| Packaging | Weight, sealing, label | Statutory ±2% weight tolerance | Calibrated weighing + visual + leak test |
Location advantages
- Sector cluster proximity
Non-woven fabric: Welspun, Ginni Filaments, local textile clusters (Ahmedabad, Surat)
- Buyer concentration
Government hospitals (e.g., AIIMS, ESIC, State Health Dept tenders) demand is concentrated in your operating region — see local-signal section for district-level checks.
- Scheme + subsidy access
PMEGP + CGTMSE are actively releasing funds in 2026 — your nodal officer is the entry point.
- Skilled labour availability
NSDC HSS/Q5201 — Medical Device Manufacturing Technician (60-day program, Healthcare Sector Skill Council) runs in most Tier-2 cities, ensuring trained operators are reachable.
- Logistics + compliance ecosystem
BIS-accredited labs + GeM vendor onboarding + APEDA / Spice Board / MNRE empanelment all available within 200 km in most operating states.
Are you eligible? (check before applying)
Every line below is a hard gate. If even one is "no", fix it before filing the PMEGP application — rejection at this stage costs you 30-60 days.
- Aged 18 or above on the date of PMEGP application.PMEGP scheme guidelines, Ministry of MSME
- Minimum education: Class VIII pass for project cost > ₹10 lakh (manufacturing).PMEGP-specific · PMEGP scheme guidelines, Ministry of MSME
- No prior PMEGP / PMRY / REGP grant claimed by you or your family.PMEGP-specific · PMEGP scheme guidelines, Ministry of MSME
- Project cost is within the PMEGP cap: ₹50 lakh for manufacturing. Surgical adhesive tape manufacturing falls under 'manufacturing'.PMEGP-specific · PMEGP scheme guidelines, Ministry of MSME
- Indian citizen with PAN + Aadhaar + active bank account.General MSME / Udyam registration
- Site has clear title (owned, leased ≥10 yrs, or family / panchayat allotted with NOC) and is suitable for clean room setup, 3-phase power, and proper waste disposal.Bank underwriting + CDSCO site requirements
- Proprietor or a designated technical person must have relevant educational qualification (e.g., Pharmacy, Science, Engineering diploma/degree) or sufficient experience in medical device manufacturing.CDSCO Medical Device Rules 2017
- No active CIBIL default; minimum CIBIL score 650+ helps but isn't mandatory for PMEGP.Indian Banks Association underwriting norm
The numbers are one tap away
You've seen whether this business fits. The full Smart DPR — every cost, the 5-year P&L, EMI schedule, sensitivity, bank-grade accounting and the downloadable PDF — is free. Just sign in with your phone (30 seconds, no payment).
- Project cost (May 2026 prices)
- Means of finance & bank loan EMI schedule
- Steady-state profit & loss
- 5-year ramp projection & scenarios
- Sensitivity analysis
- Personal-fit & local-market checks
- Application sequence & timeline
- Subsidy stack, compliance & sourcing
- Bank-grade accounting (balance sheet, cash flow, depreciation)
- Full source citations
This Smart DPR is an editorial reconstruction by BharatSeal using public market data. It is not a substitute for a bank-signed DPR — your branch manager will require their own underwriting before sanctioning. KVIC original at kviconline.gov.in.